Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

Thomas J. Guzzo, S. Bruce Malkowicz, Daniel Canter et al.|Urologic Oncology Seminars and Original Investigations|2011

Cited by 38